RAXTEMY Trademark

Trademark Overview

On Monday, June 15, 2020, a trademark application was filed for RAXTEMY with the United States Patent and Trademark Office. The USPTO has given the RAXTEMY trademark a serial number of 90001765. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 22, 2024. This trademark is owned by Mylan Pharmaceuticals, Inc.. The RAXTEMY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of asthma in patients 6 years of age and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema; Anti-inflammatories
raxtemy

General Information

Serial Number90001765
Word MarkRAXTEMY
Filing DateMonday, June 15, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of asthma in patients 6 years of age and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema; Anti-inflammatories

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMylan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505
Party NameMylan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505

Trademark Events

Event DateEvent Description
Monday, January 22, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 22, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, June 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 29, 2023SOU EXTENSION 5 GRANTED
Wednesday, June 21, 2023SOU EXTENSION 5 FILED
Thursday, June 29, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 21, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 21, 2022SOU EXTENSION 4 GRANTED
Wednesday, December 21, 2022SOU EXTENSION 4 FILED
Wednesday, December 21, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 15, 2022SOU EXTENSION 3 GRANTED
Wednesday, June 15, 2022SOU EXTENSION 3 FILED
Wednesday, June 15, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 1, 2021SOU EXTENSION 2 GRANTED
Wednesday, December 1, 2021SOU EXTENSION 2 FILED
Wednesday, December 1, 2021SOU TEAS EXTENSION RECEIVED
Thursday, November 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 18, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, June 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 21, 2021SOU EXTENSION 1 GRANTED
Monday, June 21, 2021SOU EXTENSION 1 FILED
Monday, June 21, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 27, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 17, 2020ASSIGNED TO EXAMINER
Monday, July 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 18, 2020NEW APPLICATION ENTERED

Related Keywords

raxtemy treatment patients chronic disease pulmonary obstructive copd emphysema inflammatories anti